StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Payments related to current year product sales by Year

Payments related to current year product sales ($M) ($M)

Gilead Sciences Payments related to current year product sales: $13,064M in FY2025, up 13.5% from a year earlier.

Latest, FY2025
13,064
Period ended Dec 31, 2025
Change on a year earlier
+13.5%
11,508 in FY2024
History
13 years
Since FY2013
Sources
12
Documents cited below

Where the FY2025 figure comes from

“|| Activity related to 2025 sales | $ | — | $ | 17,880 | $ | (13,064) | $ | 4,816”

Source: Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗

Reported in Form 10-K Critical Accounting Estimates.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPayments related to current year product sales ($M) ($M)Year on yearSource
FY2025Dec 31, 202513,064+13.5%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
FY2024Dec 31, 202411,508+10.8%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
FY2023Dec 31, 202310,389+10.0%Form 10-K (gild-20241231.htm, filed 2025-02-28) ↗
FY2022Dec 31, 20229,442-2.8%Form 10-K (gild-20231231.htm, filed 2024-02-23) ↗
FY2021Dec 31, 20219,714+2.3%Form 10-K (gild-20221231.htm, filed 2023-02-22) ↗
FY2020Dec 31, 20209,500-4.2%Form 10-K (gild-20211231.htm, filed 2022-02-23) ↗
FY2019Dec 31, 20199,920-9.4%Form 10-K (gild-20201231.htm, filed 2021-02-25) ↗
FY2018Dec 31, 201810,953-1.9%Form 10-K (a2019form10-k.htm, filed 2020-02-25) ↗
FY2017Dec 31, 201711,170-19.8%Form 10-K (a2018form10-k.htm, filed 2019-02-26) ↗
FY2016Dec 31, 201613,920+20.0%Form 10-K (a2017form10-k.htm, filed 2018-02-27) ↗
FY2015Dec 31, 201511,597+217.7%Form 10-K (a2016form10-k.htm, filed 2017-02-27) ↗
FY2014Dec 31, 20143,650+54.9%Form 10-K (a2015form10-k.htm, filed 2016-02-24) ↗
FY2013Dec 31, 20132,357–Form 10-K (a2014form10-k.htm, filed 2015-02-25) ↗

Cite this data

StockData. (2026). Gilead Sciences Payments related to current year product sales ($M), annual FY2013–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/reb-pay-curr

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.